A potential oncogenic role for the NF-κB signaling pathway in lymphomas was originally postulated few years after the discovery of the pathway in the 1980s, based on the observation of constitutive NF-κB activity in classical Hodgkin lymphoma (cHL) cell lines [1]. This evidence concerns the gene NFKB1 and lymphoma.